GENEVA, July 2 -- ALEXION PHARMACEUTICALS, INC. filed a patent application (US2025/021821) for “KIDNEY ACTIVE FUSION PROTEINS AND METHODS OF TREATMENT USING THE SAME”. With publication no. WO/2026/135714, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 38/17
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....